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S U M M A R Y
Background: Procedures involving the use of Mycobacterium leprae and Lacazia loboi, uncultivated
organisms, depend on the collection of material from the lesions of patients or experimental animals.
This study compared ﬁne-needle aspiration (FNA) and skin biopsy methods for obtaining bacilli and
fungal cells to experimentally infect animals.
Methods: Lepromas from one armadillo and one enlarged footpad of amouse previously inoculatedwith
L. loboi were submitted to FNA and biopsy. Materials collected were processed for inoculation in mice.
Results: Acid-fast bacilli (AFB) collected by two FNA procedures yielded 7.2  107 and 5.3  106 AFB/ml
and biopsies yielded 1.58  108 and 3.5  108 AFB/ml from each leproma. Yeast-like cells of L. loboi
collected by FNA yielded 1.0  106 fungal cells/ml and biopsy 1.0  107 fungal cells/ml. After 8 months,
inoculated animals were sacriﬁced and the inoculated footpads submitted to histopathological
examination and counting of AFB and fungal cells. The results obtained by the two methods were
comparable for both microorganisms.
Conclusions: Biopsy may be replaced by FNA during harvesting of material for different purposes,
especially for experimental inoculation ofmice in leprosy and Jorge Lobo’s disease, with the advantage of
FNA being a simpler, less invasive, and less costly method.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Experimental animal models for leprosy and Jorge Lobo’s
disease are commonly used to elucidate the pathogenesis of both
infectious diseases, in drug susceptibility testing, andmaintenance
of strains.1–3Mycobacterium leprae, the etiologic agent of leprosy, is
the only species of the genus that has not yet been cultivated in
vitro.4 The inability of M. leprae to grow in artiﬁcial culture media
prevents the provision of large quantities of bacilli, in addition to
impeding the use of bacilli in routine diagnostic procedures and
research, such as determining bacillary viability and verifying the
presence of viable bacilli in the lesions of patients after dismissal
from treatment and during reactional episodes. In these cases,
bacilli are routinely obtained by incisional skin biopsies.5
Jorge Lobo’s disease, also known as lacaziosis, is a chronic
cutaneous mycosis that occurs in the Amazon basin. Its etiologic
agent, the fungus Lacazia loboi,6 similarly to M. leprae, does not
grow in artiﬁcial media. The fungal cells used in routine research* Corresponding author. Tel.: +55 14 3103 5911; fax: +55 14 3103 5914.
E-mail address: prosa@ilsl.br (P.S. Rosa).
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doi:10.1016/j.ijid.2009.11.003procedures need to be collected from lesions of patients or
experimentally infected mice. The fungal cells are obtained from
surgical specimens or punch biopsies for the follow-up of patients
during treatment with antimicrobial drugs. Infected mice are used
for maintenance and passage of strains that are further used in
molecular and phylogenetic studies and antigen preparation.7,8
Because both M. leprae and L. loboi are highly adapted to their
respective hosts, the experimental procedures used for inoculation
require viable microorganisms; therefore, samples should be
processed rapidly and animals inoculated soon after thematerial is
collected from the host, whether human or animal.9,10
One simple, low cost, and minimally invasive technique widely
used in the routine cytologic diagnosis of neoplasias and non-
neoplastic diseases, including infectious diseases, is ﬁne-needle
aspiration (FNA). Thematerial collected by FNA is in general highly
cellular, which in most cases allows the diagnosis of diseases
without the need for a biopsy. FNA also allows the performance of
histochemical, immunohistochemical, and molecular techniques
for the identiﬁcation of infectious agents and the searching for
oncogenic proteins and speciﬁc molecular changes causing
disease. The results of FNA reported in the literature are
comparable to the results of biopsy,11–14 and for the diagnosisses. Published by Elsevier Ltd. All rights reserved.
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be as speciﬁc as PCR.15
Despite its use in diagnostic procedures, there are no reports of
the use of FNA to collect material for the experimental inoculation
of animals. This study therefore aimed to compare the two
methods for obtaining viable bacilli and fungi, for further use in
experimental leprosy and Jorge Lobo’s disease.
2. Materials and methods
2.1. FNA technique
FNAwas performedwith a 0.60  25 needle (23 G 1) coupled to
a 10 ml syringe, which was attached to a hand-grip syringe holder.
The procedure consisted of introduction of the needle into the
tissue and suction while moving the needle back and forth
repeatedly, as recommended previously.15,16 Enough material was
considered to have been obtained when the hub of the needle was
ﬁlled with aspirate, then pressure applied on the syringe was
released and the needle removed from the lesion.
2.2. M. leprae collection from armadillo lepromas by FNA and biopsy
Acid-fast bacilli (AFB) were collected from two lepromas of one
armadillo (Dasypus novemcinctus; samples FNA 1 and FNA 2),
which had previously been inoculated with M. leprae. The animal
received pre-anesthetic medication (atropine sulfate 0.04 ml/kg,
administered subcutaneously) and was then anesthetized with
Zoletil1 (tiletamine–zolazepan 0.2 ml/kg, administered intramus-
cularly). The area around the collection site was cleaned with
alcohol prior to the FNA procedure. The aspirated materials were
immediately individually suspended in 2.0 ml of Hank’s salt
solution. The obtained AFB suspensions were counted and
inoculated in mice. Two incisional biopsies (BIOPSY 1 and BIOPSY
2) were performed at the same sites from which the ﬁne-needle
aspirates were taken. The two tissue fragments obtained were
weighed (0.08 g and 0.12 g) and processed individually for
counting and mouse inoculation.
2.3. L. loboi collection from the footpad of a mouse by FNA and biopsy
The FNA procedure for the fungal lesion in the mouse footpad
was the same as that used for the armadillo lepromas. The L. loboi
fungal cells were collected from a previously inoculated mouse.
The animal was anesthetized (xylazine 10 mg/kg and ketamine
115 mg/kg, administered intraperitoneally) and after cleaning
with alcohol, the footpad was aspirated twice to obtain enough
material. Cells were suspended in 2.0 ml of sterile saline solution.
Viability and the number of fungi in the suspension were
determined, and then the fungal cells were inoculated in mice
according to the protocol described by Belone et al.8 After the FNA
procedure, the donor mouse was sacriﬁced by cervical dislocation.
The enlarged footpad was excised, weighed (0.24 g), and macerat-
ed for counting and inoculation.
2.4. AFB counting
The FNA materials were homogenized with the same syringes
used in the aspiration prior to counting of the AFB. The biopsies,
however, were macerated in a tissue grinder containing 2.0 ml of
Hank’s salt solution; 10 ml of the suspension were placed on three
1.0 cm diameter circles on a glass slide for counting. After air
drying, the slides were ﬁxed and stained using the Ziehl–Neelsen
technique. The numbers of AFB present in the suspensions were
estimated from 60 microscopic ﬁelds, calculated according to the
protocol previously described.172.5. Evaluation of viability and counting of fungal cells
The FNA materials were homogenized using the same syringes
used in the aspiration prior to counting of the fungal cells. The
footpads were macerated in 2.0 ml of saline solution and then the
suspension was ﬁltered in two-ply gauze to eliminate the cellular
debris. The volume of the fungal suspensionwas adjusted to 2.0 ml
for counting, viability determination, and inoculation. The viability
of the fungi was determined by ethidium bromide–ﬂuorescein
diacetate (DF–BE) vital staining, according to the protocol
described by Vilani-Moreno and Opromolla.18
2.6. Inoculation
Inoculation of both organisms obtained by FNA and biopsy was
performed intradermally in both hind footpads of 8-week-oldmale
BALB/cmice. Animalsweremaintained at 21 8C and receivedwater
and food ad libitum. For M. leprae, 40 mice (80 footpads) were
inoculated with 1  104 AFB/footpad. Mice were divided into four
groups of 10 animals: FNA 1 and FNA 2, groups that were
inoculated with material from two different FNA procedures;
BIOPSY 1 and BIOPSY 2, groups that were inoculated with material
from two different biopsies. For L. loboi, 10mice (20 footpads)were
inoculated with 1  105 fungal cells/footpad. Mice were divided
into two groups of ﬁve animals: FNA 3, group inoculatedwith FNA-
collected fungi; BIOPSY 3, group inoculated with biopsy material.
2.7. Sacriﬁce of inoculated mice
All animals were sacriﬁced 8 months after inoculation by
cervical dislocation after sedation. Both footpads were excised; the
right was submitted to histopathological examination and the left
was macerated for counting of fungal cells or AFB, as previously
described for the preparation of the suspensions. This study was
approved by the Animal Ethics Committee of the Universidade do
Sagrado Corac¸a˜o, Bauru, Sa˜o Paulo, Brazil.
2.8. Histopathological evaluation
The histopathological evaluation and bacterial index determi-
nation of the material obtained from the footpads of M. leprae
inoculated mice were done in hematoxylin–eosin (HE) and Fite–
Faraco stained sections. The bacterial index for histological
sections was the same as that used for skin biopsies of leprosy
patients, on a scale from 0 to 6+.19 The histopathological evaluation
of the material obtained from footpads of L. loboi inoculated mice
was done in HE and methenamine silver stained sections.
2.9. Statistical analysis
The non-parametric Mann–Whitney test was used for compar-
ison of the mean and median of bacilli and fungi recovered from
experimentally infected animals.
3. Results
The number of AFB and fungal cells obtained by the two
different methods did not vary greatly for the lepromas of the
armadillo or the L. loboimouse footpad lesion (Table 1). The FNA 1
and FNA 2 procedures yielded 7.2  107 and 5.3  106 AFB/ml
respectively, while the biopsy procedures BIOPSY 1 and BIOPSY 2
yielded 1.58  108 and 3.5  108 AFB/ml, respectively. For L. loboi,
1.0  106 fungal cells/ml were collected by FNA and 1.0  107
fungal cells/ml were obtained from the excised footpad (Table 1).
The mean number of bacilli recovered in suspensions from
material collected from the mice footpads after 8 months of
Table 1
Number of AFB and fungal cells obtained by FNA and biopsy from lepromas of an armadillo experimentally infected withMycobacterium leprae (FNA 1 and 2/BIOPSY 1 and 2)
and from a mouse experimentally infected with Lacazia loboi (FNA 3 and BIOPSY 3); mean AFB/ml, bacterial index, median number of fungal cells, and viability of fungi in
organisms recovered from infected animals.
Organisms collected for inoculation Organisms recovered from infected animals
Group No. of fungal cells
or bacilli






FNA 1 7.2107 AFB/ml 2.1105 a 3+ to 6+ NA NA
FNA 2 5.3106 AFB/ml 1.4105 b 4+ to 6+ NA NA
FNA 3 1.0106 fungal cells/ml NA NA 1.44106 c 4.5 d
(15–500104) (0–65)
BIOPSY 1 1.58108 AFB/ml 2.1105 a 3+ to 5+ NA NA
BIOPSY 2 3.5108 AFB/ml 1.9105 b 3+ to 5+ NA NA
BIOPSY 3 1.0107 fungal cells/ml NA NA 8.1105 c 7.0 d
(1–270104) (1–30)
AFB, acid-fast bacilli; BI, bacterial index; FNA, ﬁne-needle aspiration; NA, not applicable.
Mann–Whitney non-parametric test, no statistical differences: ap=0.236; bp=0.606; cp=0.756; dp=0.968.
Fig. 2. Histology image showing M. leprae bacilli inside macrophages (Faraco–Fite
stain, 1000).
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AFB/ml for FNA 1 and 1.4  105 AFB/ml for FNA 2. In the biopsy
groups, the total numbers of bacilli recovered were 2.1  105 AFB/
ml in BIOPSY 1 and 1.9  105 AFB/ml in BIOPSY 2 (Table 1). The
median number of fungal cells recovered from the footpads ofmice
after inoculation was comparable in the two groups: the FNA 3
group had 1.44  106 fungal cells/ml and the BIOPSY 3 group had
8.1  105 fungal cells/ml, with viability indices of 4.5% and 7.0%,
respectively (Table 1). Thus, comparison of the data obtained from
the same site showed no statistical difference, which demonstrates
that both methods yielded enough material for analysis and
infection of mice.
The histological pattern in mice inoculated with M. leprae did
not vary in any of the groups. A diffuse lymphohistiocytic
granulomatous inﬁltrate penetrating the dermis, skeletal muscle
layer, and nerves was observed in most examined slides. The
bacterial index varied from 3 to 6+, with a predominance of
granular bacilli. Foci of necrosis associated with neutrophilic
inﬁltrate were observed in a few animals (Figs. 1 and 2).
The histological pattern in mice inoculated with L. loboi was
identical in both the FNA and BIOPSY groups. A lymphohistiocytic
granulomatous reaction involving the dermis, skeletal muscle
layer, and nerve branches was observed. A large number of fungal
cells were observed inside histiocytes and multinucleated giant
cells. Lymphocytes and plasma cells were also observed permeat-
ing the granulomatous inﬁltrate (Figs. 3 and 4).Fig. 1. Histology image of a Mycobacterium leprae inoculated mouse footpad
showing a chronic inﬂammatory process and lymphohistiocytic granulomas on the
dermis, involving vessels and skeletal muscle. Areas of necrosis in the superﬁcial
dermis can also be seen (hematoxylin and eosin, 100  ) .4. Discussion
M. leprae used in experimental laboratory procedures are
commonly obtained from skin biopsies from leprosy patients.
Because M. leprae has not yet been cultivated in vitro, animals are
routinely inoculated to evaluate the drug sensitivity proﬁle of M.Fig. 3. Histology image of the L. loboi inoculated mouse footpad showing a chronic
inﬂammatory process and granulomas with multinucleated macrophages
containing fungal cells, interspersed with lymphocytes and plasma cells
(hematoxylin and eosin, 400).
Fig. 4. Histology image of the L. loboi inoculated mouse footpad showing large
numbers of fungal cells inside the granulomas (methenamine silver stain, 400).
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after the end of treatment and in patients undergoing successive
reactional episodes; and to maintain strains of M. leprae in
passages into immunosuppressed mice. Another experimental
model of leprosy is the nine-banded armadillo, which develops the
disseminated form of leprosy after inoculation of massive doses of
M. leprae derived from lesions of patients, inoculated mice, or even
other armadillos. Doses of 108 to 109 M. leprae inoculated
subcutaneously and intravenously lead to the formation of nodules
at the site of inoculation (lepromas) within about 12 months and
then dissemination of the infection. These animals, therefore, have
largely been used for the production of bulk bacilli and in the
maintenance of M. leprae strains in the laboratory.1
Studies into Jorge Lobo’s disease progressed remarkably in the
last decade after the successful experimental infection of BALB/c
micewith L. loboi.7,8 Infectedmice are used in themaintenance of L.
loboi strains, for DNA extraction in phylogenetic studies, and also
for the characterization of L. loboi antigens.20–22 The preparation of
the fungal suspension to be inoculated in animals is labor-
intensive, involving the collection and maceration of fragments of
lesions in sterile conditions, washing to eliminate the host’s
cellular debris, and dilution. All of this results in a relatively long
time delay between collection and inoculation of animals, which
sometimes jeopardizes the results of experiments, probably
because fungal cells lose their viability before inoculation.
FNA is a simple, low cost, minimally invasive, and widely used
technique for routine diagnostic procedures.9,10,15,23 In general, a
highly cellularmaterial is obtained by FNA. Smears of the aspirated
material show whole cells, loose or grouped, with little or absent
stroma. Examination of smears allows thorough evaluation of
cytological characteristics and diagnosis in most cases. It is also
possible to perform several different studies on the FNA-collected
material, with results comparable to studies conducted on biopsy
material.11–15,23,24
In both experimental models, for leprosy and Jorge Lobo’s
disease, the etiologic agents are inoculated in mice footpads. For
passage into other animals or for collection of material to be
studied, it is necessary to sacriﬁce the animal host to obtain enough
bacilli or fungal cells.2,8 FNA eliminates the need for sacriﬁcing
animals to collect samples; in addition, it facilitates the prepara-
tion of cell suspensions. By using FNA, M. leprae and L. loboi are
harvested from lesions almost without tissue debris. The organ-
isms may be suspended in the appropriate media, homogenized,
counted, and immediately inoculated, providing maximal preser-
vation of viability. This way, the maceration, washing, andﬁltration steps can be spared, without the need to purify the
infectious agents from other tissue components, such as the
epidermis, ﬁbroblasts, vessels, nerves, and adnexal glands.
In the present study, the results from material inoculated with
M. leprae were highly homogeneous between the FNA and biopsy
maceration techniques (Table 1). In the animals inoculated with L.
loboi, there was a small difference between the two groups – the
FNA results appeared better than the results from material
obtained by maceration of tissue, with respect to both the number
of fungal cells and viability (Table 1); however, the difference was
not statistically signiﬁcant (p = 0.756). This may have resulted
from the fact that FNA allows for immediate inoculation, and
consequently preservation of the characteristics of the fungal cells
and bacilli, while the material submitted to processing of the
biopsy takes additional steps, as previously discussed in the
present study, which may lead to microenvironmental changes
that can ultimately hamper the growth of these microorganisms
after inoculation.
FNA has been shown to be adequate for the preparation of
material for animal inoculation,mainly because of the quantities of
organisms collected, with a good viability index. In the material
obtained by biopsy there were larger numbers of fungal cells and
bacilli than in the material obtained by FNA; however, this was
expected because the quantities of cells present in a biopsy, even a
small one, is very high (Table 1). Nevertheless, the results indicate
that the number of fungal cells and bacilli recovered from
inoculated footpads is similar between the FNA and BIOPSY groups.
There are several advantages to using FNA compared to biopsy:
lower cost of FNA, it is a less traumatic approach for the individual
submitted to collection, the procedure can be done faster, and the
collected material is well preserved; there is also no need to
sacriﬁce the animal host and sampling can be repeated at time
intervals. In addition, FNA can easily be used to collect samples in
ﬁeld conditions.
In summary, the results show that FNA may replace biopsy as a
method to harvest material for inoculation of experimental
animals and for determination of viability of L. loboi andM. leprae.
Thus, we recommend the use of the FNA procedure instead of
biopsy for experimental inoculation in both leprosy and Jorge
Lobo’s disease.
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